Advertisement

Persistent viral replication and the development of T-cell responses after intranasal infection by MCMV

  • Shunchuan Zhang
  • Sofia Caldeira-Dantas
  • Corinne J. Smith
  • Christopher M. SnyderEmail author
Original Investigation

Abstract

Natural transmission of cytomegalovirus (CMV) has been difficult to observe. However, recent work using the mouse model of murine (M)CMV demonstrated that MCMV initially infects the nasal mucosa after transmission from mothers to pups. We found that intranasal (i.n.) inoculation of C57BL/6J mice resulted in reliable recovery of replicating virus from the nasal mucosa as assessed by plaque assay. After i.n. inoculation, CD8+ T-cell priming occurred in the mandibular, deep-cervical, and mediastinal lymph nodes within 3 days of infection. Although i.n. infection induced “memory inflation” of T cells specific for the M38316–323 epitope, there were no detectable CD8+ T-cell responses against the late-appearing IE3416–423 epitope, which contrasts with intraperitoneal (i.p.) infection. MCMV-specific T cells migrated into the nasal mucosa where they developed a tissue-resident memory (TRM) phenotype and this could occur independently of local virus infection or antigen. Strikingly however, virus replication was poorly controlled in the nasal mucosa and MCMV was detectable by plaque assay for at least 4 months after primary infection, making the nasal mucosa a second site for MCMV persistence. Unlike in the salivary glands, the persistence of MCMV in the nasal mucosa was not modulated by IL-10. Taken together, our data characterize the development of local and systemic T-cell responses after intranasal infection by MCMV and define the nasal mucosa, a natural site of viral entry, as a novel site of viral persistence.

Keywords

Cytomegalovirus Nasal mucosa Intranasal infection Tissue-resident memory T cells 

Notes

Acknowledgements

This work was supported by Grant AI106810 awarded to C.M.S.

Compliance with ethical standards

Conflict of interest

The authors declare no competing interests.

Supplementary material

430_2019_589_MOESM1_ESM.pptx (5.3 mb)
Supplementary material 1 Representative gating strategies. Representative gates show the analyses of dividing CD8+ T cells to identify the sites of priming (data shown in Fig. 2), the identification of CD8+ TRM in the i.v. antibody-negative fraction of the nasal mucosa and salivary glands (data shown in Fig. 4), and phenotypic analyses of circulating virus-specific CD8+ T cells (data shown in Fig. 3). (PPTX 5387 KB)

References

  1. 1.
    Styczynski J (2018) Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther 7:1–16CrossRefGoogle Scholar
  2. 2.
    Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86–102CrossRefGoogle Scholar
  3. 3.
    Crough T, Khanna R (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22:76–98CrossRefGoogle Scholar
  4. 4.
    Mayer BT, Krantz EM, Swan D, Ferrenberg J, Simmons K, Selke S, Huang ML, Casper C, Corey L, Wald A, Schiffer JT, Gantt S (2017) Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells. J Virol 91:e00380–e00317CrossRefGoogle Scholar
  5. 5.
    Schleiss MR (2006) Role of breast milk in acquisition of cytomegalovirus infection: recent advances. Curr Opin Pediatr 18:48–52Google Scholar
  6. 6.
    Dworsky M, Yow M, Stagno S, Pass RF, Alford C (1983) Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 72:295–299Google Scholar
  7. 7.
    Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S (2003) Pathogenesis of murine cytomegalovirus infection. Microb Infect 5:1263–1277CrossRefGoogle Scholar
  8. 8.
    Wu CA, Paveglio SA, Lingenheld EG, Zhu L, Lefrancois L, Puddington L (2011) Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates. J Virol 85:5115–5124CrossRefGoogle Scholar
  9. 9.
    dela Pena MG, Strelow L, Barry PA, Abel K (2012) Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection. J Med Primatol 41:225–229CrossRefGoogle Scholar
  10. 10.
    Stahl FR, Heller K, Halle S, Keyser KA, Busche A, Marquardt A, Wagner K, Boelter J, Bischoff Y, Kremmer E, Arens R, Messerle M, Forster R (2013) Nodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lung. PLoS Pathog 9:e1003828CrossRefGoogle Scholar
  11. 11.
    Oduro JD, Redeker A, Lemmermann NA, Ebermann L, Marandu TF, Dekhtiarenko I, Holzki JK, Busch DH, Arens R, Čičin-Šain L (2016) Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection. J Gen Virol 97:185–195CrossRefGoogle Scholar
  12. 12.
    Davey A, Eastman L, Hansraj P, Hemmings DG (2011) Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts. Biol Reprod 85:198–207CrossRefGoogle Scholar
  13. 13.
    Farrell HE, Lawler C, Tan CSE, MacDonald K, Bruce K, Mach M, Davis-Poynter N, Stevenson PG (2016) Murine cytomegalovirus exploits olfaction to enter new hosts. mBio 7:e00251-16CrossRefGoogle Scholar
  14. 14.
    Zhang S, Xiang J, Van Doorsselaere J, Nauwynck HJ (2015) Comparison of the pathogenesis of the highly passaged MCMV smith strain with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal inoculation. Vet Res 46:94CrossRefGoogle Scholar
  15. 15.
    Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG (2015) Lymph node macrophages restrict murine cytomegalovirus dissemination. J Virol 89:7147–7158CrossRefGoogle Scholar
  16. 16.
    Wagner M, Jonjic S, Koszinowski UH, Messerle M (1999) Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73:7056–7060Google Scholar
  17. 17.
    Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB (2008) Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29:650–659CrossRefGoogle Scholar
  18. 18.
    Turula H, Smith CJ, Grey F, Zurbach KA, Snyder CMD (2013) Competition between T cells maintains clonal dominance during memory inflation induced by MCMV. Eur J Immunol 43:1252–1263CrossRefGoogle Scholar
  19. 19.
    Zurbach KA, Moghbeli T, Snyder CM (2014) Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay. Virol J 11:71CrossRefGoogle Scholar
  20. 20.
    Dunston D, Ashby S, Krosnowski K, Ogura T, Lin W (2013) An effective manual deboning method to prepare intact mouse nasal tissue with preserved anatomical organization. J Vis Exp 78:e50538Google Scholar
  21. 21.
    Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, Kurup D, Tandon M, Alevizos I, Snyder CM (2018) The chemokine receptor CXCR3 promotes CD8+ T Cell accumulation in uninfected salivary glands but is not necessary after murine cytomegalovirus infection. J Immunol 200:1133–1145CrossRefGoogle Scholar
  22. 22.
    Smith CJ, Caldeira-Dantas S, Turula H, Snyder CM (2015) Murine CMV infection induces the continuous production of mucosal resident T cells. Cell Rep 13:1137–1148CrossRefGoogle Scholar
  23. 23.
    Torti N, Walton SM, Brocker T, Rulicke T, Oxenius A (2011) Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 7:e1002313CrossRefGoogle Scholar
  24. 24.
    Baumann NS, Torti N, Welten SPM, Barnstorf I, Borsa M, Pallmer K, Oduro JD, Cicin-Sain L, Ikuta K, Ludewig B, Oxenius A (2018) Tissue maintenance of CMV-specific inflationary memory T cells by IL-15. PLoS Pathog 14:e1006993CrossRefGoogle Scholar
  25. 25.
    Redeker A, Welten SP, Arens R (2014) viral inoculum dose impacts memory T cell inflation. Eur J Immunol 44:1046–1057CrossRefGoogle Scholar
  26. 26.
    Quinn M, Turula H, Tandon M, Deslouches B, Moghbeli T, Snyder CM (2015) Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios. J Immunol 194:1726–1736CrossRefGoogle Scholar
  27. 27.
    Thom JT, Weber TC, Walton SM, Torti N, Oxenius A (2015) The salivary gland acts as a sink for tissue-resident memory CD8(+) T cells, facilitating protection from local cytomegalovirus infection. Cell Rep 13:1125–1136CrossRefGoogle Scholar
  28. 28.
    Snyder CM, Allan JE, Bonnett EL, Doom CM, Hill AB (2010) Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS One 5:e9681CrossRefGoogle Scholar
  29. 29.
    Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB (2011) Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 7:e1002295CrossRefGoogle Scholar
  30. 30.
    Kuttner AG, Wang SH (1934) The problem of the significance of the inclusion bodies found in the salivary glands of infants, and the occurrence of inclusion bodies in the submaxillary glands of hamsters, white mice, and wild rats (peiping). J Exp Med 60:773–791CrossRefGoogle Scholar
  31. 31.
    McCordock HA, Smith MG (1936) The visceral lesions produced in mice by the salivary gland virus of mice. J Exp Med 63:303–310CrossRefGoogle Scholar
  32. 32.
    Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski UH, Adler B (2011) Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary glands due to a fixed mutation of MCK-2. J Virol 85:10346–10353CrossRefGoogle Scholar
  33. 33.
    Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES (1999) Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 96:10881–10886CrossRefGoogle Scholar
  34. 34.
    Saederup N, Aguirre SA, Sparer TE, Bouley DM, Mocarski ES (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 75:9966–9976CrossRefGoogle Scholar
  35. 35.
    Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES (2006) Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30–38CrossRefGoogle Scholar
  36. 36.
    Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES (2014) Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microb 15:351–362CrossRefGoogle Scholar
  37. 37.
    Lemmermann NA, Krmpotic A, Podlech J, Brizic I, Prager A, Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler B (2015) Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread. PLoS Pathog 11:e1004640CrossRefGoogle Scholar
  38. 38.
    Humphreys IR, de Trez C, Kinkade A, Benedict CA, Croft M, Ware CF (2007) Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 204:1217–1225CrossRefGoogle Scholar
  39. 39.
    Jordan MC (1978) Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun 21:275–280Google Scholar
  40. 40.
    Gillet L, Frederico B, Stevenson PG (2015) Host entry by gamma-herpesviruses—lessons from animal viruses. Curr Opin Virol 15:34–40CrossRefGoogle Scholar
  41. 41.
    Price P, Allcock RJ, Coombe DR, Shellam GR, McCluskey J (1995) MHC proteins and heparan sulphate proteoglycans regulate murine cytomegalovirus infection. Immunol Cell Biol 73:308–315CrossRefGoogle Scholar
  42. 42.
    Milho R, Frederico B, Efstathiou S, Stevenson PG (2012) A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog 8:e1002986CrossRefGoogle Scholar
  43. 43.
    Shivkumar M, Milho R, May JS, Nicoll MP, Efstathiou S, Stevenson PG (2013) Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol 87:10477–10488CrossRefGoogle Scholar
  44. 44.
    Walton SM, Mandaric S, Torti N, Zimmermann A, Hengel H, Oxenius A (2011) Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog 7:e1002214CrossRefGoogle Scholar
  45. 45.
    Yunis J, Farrell HE, Bruce K, Lawler C, Sidenius S, Wyer O, Davis-Poynter N, Stevenson PG (2018) Murine cytomegalovirus degrades MHC class II to colonize the salivary glands. PLoS Pathog 14:e1006905CrossRefGoogle Scholar
  46. 46.
    Reuter S, Lemmermann NAW, Maxeiner J, Podlech J, Beckert H, Freitag K, Teschner D, Ries F, Taube C, Buhl R, Reddehase MJ, Holtappels R (2019) Coincident airway exposure to low-potency allergen and cytomegalovirus sensitizes for allergic airway disease by viral activation of migratory dendritic cells. PLoS Pathog 15:e1007595CrossRefGoogle Scholar
  47. 47.
    Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC, Wakim LM (2017) Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Proc Natl Acad Sci USA 114:5225–5230CrossRefGoogle Scholar
  48. 48.
    Beyranvand Nejad E, Ratts RB, Panagioti E, Meyer C, Oduro JD, Cicin-Sain L, Früh K, van der Burg SH, Arens R (2019) Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection. J Immunother Cancer 7:56CrossRefGoogle Scholar
  49. 49.
    Mercer JA, Wiley CA, Spector DH (1988) Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol 62:987–997Google Scholar
  50. 50.
    Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, Kuhnapfel B, Reddehase MJ, Grzimek NK (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83:8869–8884CrossRefGoogle Scholar
  51. 51.
    Dag F, Dolken L, Holzki J et al (2014) Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog 10:e1003962CrossRefGoogle Scholar
  52. 52.
    Smith CJ, Turula H, Snyder CM (2014) Systemic hematogenous maintenance of memory inflation by MCMV infection. PLoS Pathog 10:e1004233CrossRefGoogle Scholar
  53. 53.
    Seckert CK, Schader SI, Ebert S, Thomas D, Freitag K, Renzaho A, Podlech J, Reddehase MJ, Holtappels R (2011) Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T cells but are not sufficient for driving memory inflation during viral latency. J Gen Virol 92:1994–2005CrossRefGoogle Scholar
  54. 54.
    Zhang S, Xiang J, Theuns S, Desmarets LM, Trus I, Nauwynck HJ (2016) MCMV exploits the spleen as a transfer hub for systemic dissemination upon oronasal inoculation. Virus Res 217:47–54CrossRefGoogle Scholar
  55. 55.
    Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450–458CrossRefGoogle Scholar
  56. 56.
    Schenkel JM, Masopust D (2014) Tissue-resident memory T cells. Immunity 41:886–897CrossRefGoogle Scholar
  57. 57.
    Wakim LM, Woodward-Davis A, Bevan MJ (2010) Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci USA 107:17872–17879CrossRefGoogle Scholar
  58. 58.
    Lee YT, Suarez-Ramirez JE, Wu T, Redman JM, Bouchard K, Hadley GA, Cauley LS (2011) Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes. J Virol 85:4085–4094CrossRefGoogle Scholar
  59. 59.
    Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, Heath WR, Carbone FR, Gebhardt T (2012) Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci USA 109:7037–7042CrossRefGoogle Scholar
  60. 60.
    Shin H, Iwasaki A (2012) A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491:463–467CrossRefGoogle Scholar
  61. 61.
    Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, Vezys V, Masopust D (2012) Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol 188:4866–4875CrossRefGoogle Scholar
  62. 62.
    Hofmann M, Pircher H (2011) E-cadherin promotes accumulation of a unique memory CD8 T cell population in murine salivary glands. Proc Natl Acad Sci USA 108:16741–16746CrossRefGoogle Scholar
  63. 63.
    Woyciechowski S, Hofmann M, Pircher H (2017) α4 β1 integrin promotes accumulation of tissue-resident memory CD8(+) T cells in salivary glands. Eur J Immunol 47:244–250CrossRefGoogle Scholar
  64. 64.
    Arens R, Wang P, Sidney J, Loewendorf A, Sette A, Schoenberger SP, Peters B, Benedict CA (2008) Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 180:6472–6476CrossRefGoogle Scholar
  65. 65.
    Walton SM, Wyrsch P, Munks MW, Zimmermann A, Hengel H, Hill AB, Oxenius A (2008) The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 181:1128–1134CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Microbiology and Immunology, Sidney Kimmel Cancer Center, Sidney Kimmel Medical CollegeThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Life and Health Sciences Research Institute (ICVS), School of MedicineUniversity of MinhoBragaPortugal
  3. 3.PT Government Associate LaboratoryICVS/3B’sBraga/GuimarãesPortugal

Personalised recommendations